Development of eugenol-fortified fisetin-loaded nano-invasomes gel.

IF 1.2 4区 医学 Q4 PHARMACOLOGY & PHARMACY Xenobiotica Pub Date : 2025-02-01 Epub Date: 2025-04-13 DOI:10.1080/00498254.2025.2478928
Abdul Ahad, Mohammad Raish, Yousef A Bin Jardan, Abdullah M Al-Mohizea, Fahad I Al-Jenoobi
{"title":"Development of eugenol-fortified fisetin-loaded nano-invasomes gel.","authors":"Abdul Ahad, Mohammad Raish, Yousef A Bin Jardan, Abdullah M Al-Mohizea, Fahad I Al-Jenoobi","doi":"10.1080/00498254.2025.2478928","DOIUrl":null,"url":null,"abstract":"<p><p>The goal of current investigation was to develop eugenol-fortified fisetin nano-invasomes. Fisetin-loaded invasomes were prepared using thin film hydration procedure and evaluated for various parameters. Additionally, the optimised fisetin invasomes formulation (F5) was converted to fisetin invasomes gel using Carbopol<sup>®</sup> as gelling agent and evaluated for pH, spreadability, homogeneity, drug content, <i>in vitro</i> fisetin release, antioxidant activity and stability study.Prepared optimised fisetin invasomes formulation (F5) demonstrated vesicles size, PDI, zeta potential and entrapment efficiency of 153.85 ± 14.32 nm, 0.208 ± 0.042, -12.67 ± 1.08 mV and 72.10 ± 6.36%. The TEM image indicated that the prepared invasomes vesicles are intact, spherical and found in the range of nanosized scale. Prepared fisetin invasomes gel showed better spreadability and <i>in vitro</i> fisetin released in contrast to fisetin control gel. Substantial improvement in the DPPH radical scavenging activity of fisetin invasomes gel 44.70% (3.1 µM) and 83.94% (50 µM), was noted as compared to the control gel at 39.47% (3.1 µM) and 79.10% at (50 µM). The prepared fisetin invasomes gel formulation was found stable at 4 °C.Based on the results, prepared invasomes gel formulation was found as a viable method for better delivery of bioactive compound(s) including fisetin.</p>","PeriodicalId":23812,"journal":{"name":"Xenobiotica","volume":" ","pages":"140-149"},"PeriodicalIF":1.2000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Xenobiotica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00498254.2025.2478928","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/13 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

The goal of current investigation was to develop eugenol-fortified fisetin nano-invasomes. Fisetin-loaded invasomes were prepared using thin film hydration procedure and evaluated for various parameters. Additionally, the optimised fisetin invasomes formulation (F5) was converted to fisetin invasomes gel using Carbopol® as gelling agent and evaluated for pH, spreadability, homogeneity, drug content, in vitro fisetin release, antioxidant activity and stability study.Prepared optimised fisetin invasomes formulation (F5) demonstrated vesicles size, PDI, zeta potential and entrapment efficiency of 153.85 ± 14.32 nm, 0.208 ± 0.042, -12.67 ± 1.08 mV and 72.10 ± 6.36%. The TEM image indicated that the prepared invasomes vesicles are intact, spherical and found in the range of nanosized scale. Prepared fisetin invasomes gel showed better spreadability and in vitro fisetin released in contrast to fisetin control gel. Substantial improvement in the DPPH radical scavenging activity of fisetin invasomes gel 44.70% (3.1 µM) and 83.94% (50 µM), was noted as compared to the control gel at 39.47% (3.1 µM) and 79.10% at (50 µM). The prepared fisetin invasomes gel formulation was found stable at 4 °C.Based on the results, prepared invasomes gel formulation was found as a viable method for better delivery of bioactive compound(s) including fisetin.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
丁香酚强化非瑟酮纳米侵入体凝胶的研制。
1. 本研究的目的是开发丁香酚强化非瑟酮纳米侵入体。采用薄膜水化法制备了非瑟酮负载的浸润体,并对其各项参数进行了评价。此外,以卡波波尔®为胶凝剂,将优化后的非瑟酮侵入体制剂(F5)转化为非瑟酮侵入体凝胶,并对pH、涂敷性、均匀性、药物含量、体外非瑟酮释放量、抗氧化活性和稳定性进行了评价。制备的最佳非塞酮侵入体制剂(F5)的囊泡大小、PDI、zeta电位和包封效率分别为153.85±14.32 nm、0.208±0.042、-12.67±1.08 mV和72.10±6.36%。透射电镜结果表明,所制备的侵入体囊泡结构完整,呈球形,在纳米尺度范围内。与非瑟酮对照凝胶相比,制备的非瑟酮侵入凝胶具有更好的铺展性和体外非瑟酮释放。与对照凝胶(39.47%(3.1µM)和79.10%(50µM)相比,非塞酮侵入体凝胶的DPPH自由基清除活性分别有44.70%(3.1µM)和83.94%(50µM)的显著提高。制备的非瑟酮侵入体凝胶制剂在4°c下稳定。基于这些结果,我们发现制备的侵入体凝胶制剂是一种更好地递送包括非瑟酮在内的生物活性化合物的可行方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Xenobiotica
Xenobiotica 医学-毒理学
CiteScore
3.80
自引率
5.60%
发文量
96
审稿时长
2 months
期刊介绍: Xenobiotica covers seven main areas, including:General Xenobiochemistry, including in vitro studies concerned with the metabolism, disposition and excretion of drugs, and other xenobiotics, as well as the structure, function and regulation of associated enzymesClinical Pharmacokinetics and Metabolism, covering the pharmacokinetics and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in manAnimal Pharmacokinetics and Metabolism, covering the pharmacokinetics, and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in animalsPharmacogenetics, defined as the identification and functional characterisation of polymorphic genes that encode xenobiotic metabolising enzymes and transporters that may result in altered enzymatic, cellular and clinical responses to xenobioticsMolecular Toxicology, concerning the mechanisms of toxicity and the study of toxicology of xenobiotics at the molecular levelXenobiotic Transporters, concerned with all aspects of the carrier proteins involved in the movement of xenobiotics into and out of cells, and their impact on pharmacokinetic behaviour in animals and manTopics in Xenobiochemistry, in the form of reviews and commentaries are primarily intended to be a critical analysis of the issue, wherein the author offers opinions on the relevance of data or of a particular experimental approach or methodology
期刊最新文献
Physiologically based pharmacokinetic (PBPK) modelling and simulation based integrative approach to assess natural product-drug interactions - effect of glycyrrhetinic acid on quetiapine. Green Synthesis of Zinc Oxide Nanoflowers Using Camellia sinensis Extract and Evaluation of Their Xenobiotic-Like Cellular, Apoptotic, and Inflammatory Responses in Fibroblast Cells. Methyl mercury pharmacokinetics in man: a five-compartment hybrid model. Mass balance and metabolite profiling of 14C-Zalunfiban in humans following single-dose subcutaneous administration. l-Arginine combined with 5-fluorouracil inhibits EMT by regulating iNOS expression in hepatocellular carcinoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1